Eikon Therapeutics, Inc. (EIKN) Income Statement

28 Followers

Eikon Therapeutics, Inc. Income Statement

Last quarter (Q2 2026), Eikon Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q2, Eikon Therapeutics, Inc.'s net income was $-88.41M. See Eikon Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25
Total Revenue	$ 0.00
Gross Profit	$ -24.18M
Operating Expenses	$ 314.77M
Depreciation and Amortization	$ 24.18M
EBITDA	$ -299.24M
Operating Income	$ -338.94M
Other Income/Expenses	$ 14.70M
Pretax Income	$ -324.25M
Net Income	$ -324.25M
Per Share Metrics
Basic EPS	$ -6.16
Diluted EPS	$ -6.16
Weighted Average Shares Outstanding	54.14M
Weighted Average Shares Outstanding (Diluted)	54.14M

Currency in USD

Eikon Therapeutics, Inc. (EIKN) Income Statement

Eikon Therapeutics, Inc. Income Statement

Eikon Therapeutics, Inc. Earnings and Revenue History